Press release
Gene and Cell Therapies Targeting CNS Disorders Market Size And Global Industry Forecast 2034
Gene and Cell Therapies Targeting CNS Disorders Market
The Gene and Cell Therapies Targeting Central Nervous System (CNS) Disorders Market is entering a groundbreaking growth phase, fueled by unprecedented advances in gene editing, regenerative medicine, and targeted delivery platforms. These therapies offer potential cures or long-term remission for debilitating neurological conditions such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and spinal muscular atrophy (SMA). With a strong surge in FDA and EMA approvals for advanced therapies and a rapidly expanding clinical trial landscape, the market is poised for remarkable expansion over the next decade.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70785
Market Overview - Key Highlights
• Market Size 2024: USD 4.85 billion
• Forecasted Market Size 2034: USD 18.92 billion
• CAGR (2024-2034): ~14.5%
• Key Growth Drivers: Advances in viral and non-viral delivery systems, expanding orphan drug approvals, and significant venture capital and biopharma investments.
• Challenges: High therapy costs, manufacturing complexities, and regulatory hurdles.
• Leading Players: Novartis AG, Biogen Inc., Sarepta Therapeutics, Bluebird Bio Inc., PTC Therapeutics, Voyager Therapeutics, uniQure N.V., Sangamo Therapeutics.
Market Segmentation
By Therapy Type
• Gene Replacement Therapy
• Gene Editing Therapy (CRISPR, TALEN, ZFN)
• Cell Therapy (Neural Stem Cells, Mesenchymal Stem Cells)
By Target Indication
• Parkinson's Disease
• Alzheimer's Disease
• Multiple Sclerosis
• Amyotrophic Lateral Sclerosis (ALS)
• Spinal Muscular Atrophy (SMA)
• Others
By Vector Type
• Viral Vectors (AAV, Lentivirus, Retrovirus)
• Non-Viral Vectors (Lipid Nanoparticles, Electroporation)
By End-User
• Hospitals & Specialty Clinics
• Research & Academic Institutes
• Biopharmaceutical Companies
Segmentation Summary:
Gene replacement therapy dominates due to successful SMA and inherited retinal disease approvals, while cell therapies are emerging in regenerative neurodegenerative disease applications. AAV vectors remain the gold standard for CNS-targeted delivery, but non-viral vectors are gaining traction for safety and scalability.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70785
Regional Analysis
• North America:
Largest market share, driven by strong biopharma R&D, robust funding ecosystems, and early adoption of advanced therapies.
• Europe:
Significant growth supported by EMA regulatory support for ATMPs (Advanced Therapy Medicinal Products) and active rare disease networks.
• Asia-Pacific:
Fastest-growing region with expanding gene therapy manufacturing capacity, supportive government policies, and rapidly rising neurological disease prevalence.
• Middle East & Africa:
Gradual adoption through medical tourism and specialized neurology centers in Gulf nations.
• Latin America:
Steady progress, with Brazil and Argentina leading clinical trial activity and patient access programs.
Regional Summary:
North America will maintain dominance, but Asia-Pacific will post the highest CAGR as domestic biotech innovation and manufacturing scale up.
Market Dynamics
Key Growth Drivers:
• Rapid progress in targeted CNS gene delivery technology.
• Expanding approval rate for orphan and rare disease therapies.
• Strategic partnerships between academic institutions and biopharma companies.
Key Challenges:
• High therapy pricing limiting patient accessibility.
• Regulatory uncertainties in emerging markets.
• Manufacturing and scalability hurdles.
Latest Trends:
• Development of intrathecal and intraparenchymal delivery techniques for precise CNS targeting.
• Combination of gene and cell therapies for enhanced neuroregeneration.
• Expansion of off-the-shelf allogeneic cell therapy platforms.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70785/gene-and-cell-therapies-targeting-cns-disorders-market
Competitive Landscape
Major Players:
1. Novartis AG
2. Biogen Inc.
3. Sarepta Therapeutics
4. Bluebird Bio Inc.
5. PTC Therapeutics
6. Voyager Therapeutics
7. uniQure N.V.
8. Sangamo Therapeutics
9. Regenxbio Inc.
10. Neuralstem Inc.
Competition Summary:
The market is highly innovation-driven, with companies racing to secure first-mover advantages in niche neurological indications. Partnerships, licensing deals, and venture-backed funding rounds are accelerating time-to-market.
Conclusion
The Gene and Cell Therapies Targeting CNS Disorders Market is set for double-digit growth through 2034, driven by breakthrough technologies, growing clinical trial pipelines, and increasing regulatory support for advanced therapies. Companies that focus on delivery innovation, cost optimization, and multi-indication expansion will shape the next decade of neurological treatment paradigms.
This report is also available in the following languages : Japanese (中枢神経系疾患市場をターゲットとした遺伝子・細胞治療), Korean (중추신경계 질환을 타깃으로 하는 유전자 및 세포 치료제 시장), Chinese (针对中枢神经系统疾病的基因和细胞疗法市场), French (Marché des thérapies géniques et cellulaires ciblant les troubles du système nerveux central), German (Markt für Gen- und Zelltherapien zur Behandlung von ZNS-Erkrankungen), and Italian (Mercato delle terapie geniche e cellulari mirate ai disturbi del sistema nervoso centrale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70785
Our More Report:
Industrial Cabinet Air Conditioner Market
https://exactitudeconsultancy.com/request-sample/64880
Holographic Foil Market
https://exactitudeconsultancy.com/request-sample/64878
Automotive Aroma Diffuser Market
https://exactitudeconsultancy.com/request-sample/64876
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene and Cell Therapies Targeting CNS Disorders Market Size And Global Industry Forecast 2034 here
News-ID: 4141734 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
